Page last updated: 2024-10-22

ambroxol and Cystic Fibrosis of Pancreas

ambroxol has been researched along with Cystic Fibrosis of Pancreas in 11 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Research Excerpts

ExcerptRelevanceReference
"The therapeutic efficacy of oral N-acetylcysteine (NAC) and ambroxol as compared with the effect of placebos was studied in 36 cystic fibrosis (CF) patients with mild to moderate pulmonary disease."9.05A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis. ( Bender, SW; Hofmann, D; Posselt, HG; Ratjen, F; Stöver, B; Wönne, R, 1985)
"Ambroxol, a mucokinetic anti-inflammatory drug, has been used for treatment of cystic fibrosis (CF)."7.79The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells. ( Hussain, R; Johannesson, M; Oliynyk, I; Roomans, GM; Strid, H; Varelogianni, G, 2013)
"The therapeutic efficacy of oral N-acetylcysteine (NAC) and ambroxol as compared with the effect of placebos was studied in 36 cystic fibrosis (CF) patients with mild to moderate pulmonary disease."5.05A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis. ( Bender, SW; Hofmann, D; Posselt, HG; Ratjen, F; Stöver, B; Wönne, R, 1985)
"Ambroxol, a mucokinetic anti-inflammatory drug, has been used for treatment of cystic fibrosis (CF)."3.79The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells. ( Hussain, R; Johannesson, M; Oliynyk, I; Roomans, GM; Strid, H; Varelogianni, G, 2013)
"Cystic fibrosis is an inherited condition resulting in thickened, sticky respiratory secretions."2.49Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. ( Nash, EF; Ratjen, F; Stephenson, A; Tam, J; Tullis, E, 2013)
"Cystic fibrosis is an inherited condition resulting in thickened, sticky respiratory secretions."2.45Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. ( Nash, EF; Ratjen, F; Stephenson, A; Tullis, E, 2009)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's2 (18.18)18.2507
2000's3 (27.27)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Varelogianni, G1
Hussain, R1
Strid, H1
Oliynyk, I1
Roomans, GM1
Johannesson, M1
Tam, J1
Nash, EF2
Ratjen, F3
Tullis, E2
Stephenson, A2
Dhar, R1
Sharafkhaneh, A1
Velamuri, S1
Badmaev, V1
Lan, C1
Hanania, N1
Akkoca Yildiz, O1
Romano, C1
Gargani, GF1
Minicucci, L1
Nantron, M1
Zapletal, A1
Vávrová, V1
Stefanová, J1
Horák, J1
Samánek, M1
Serrano, J1
Sanchis, J1
Derelle, J1
Bertolo-Houriez, E1
Marchal, F1
Weber, M1
Virion, JM1
Vidailhet, M1
Wönne, R1
Posselt, HG1
Stöver, B1
Hofmann, D1
Bender, SW1

Reviews

6 reviews available for ambroxol and Cystic Fibrosis of Pancreas

ArticleYear
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
    The Cochrane database of systematic reviews, 2013, Jul-12, Issue:7

    Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fi

2013
Role of mucolytics in wet cough.
    The Journal of the Association of Physicians of India, 2013, Volume: 61, Issue:5 Suppl

    Topics: Ambroxol; Asthma; Bronchodilator Agents; Cholinergic Antagonists; Cough; Cystic Fibrosis; Expectoran

2013
The potential role of natural agents in treatment of airway inflammation.
    Therapeutic advances in respiratory disease, 2007, Volume: 1, Issue:2

    Topics: Ambroxol; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Cystic Fibrosis; Diet; Expectorants; Hu

2007
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
    The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1

    Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Ambroxol; Carbocysteine; Cystic Fi

2009
[Ambroxol].
    Tuberkuloz ve toraks, 2006, Volume: 54 Suppl 1

    Topics: Ambroxol; Anti-Inflammatory Agents; Antioxidants; Asthma; Bronchial Hyperreactivity; Cystic Fibrosis

2006
[Usefulness of mucoactive drugs in respiratory diseases].
    Archivos de bronconeumologia, 1998, Volume: 34, Issue:1

    Topics: Acetylcysteine; Ambroxol; Bromhexine; Bronchiectasis; Bronchitis; Cystic Fibrosis; Deoxyribonuclease

1998

Trials

2 trials available for ambroxol and Cystic Fibrosis of Pancreas

ArticleYear
[Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience].
    Minerva pediatrica, 1984, Feb-15, Volume: 36, Issue:3

    Topics: Acetylcysteine; Adolescent; Ambroxol; Bromhexine; Bronchial Diseases; Child; Child, Preschool; Clini

1984
A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.
    European journal of pediatrics, 1985, Volume: 144, Issue:4

    Topics: Acetylcysteine; Adolescent; Adult; Ambroxol; Bromhexine; Child; Clinical Trials as Topic; Cystic Fib

1985

Other Studies

3 other studies available for ambroxol and Cystic Fibrosis of Pancreas

ArticleYear
The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
    Cell biology international, 2013, Volume: 37, Issue:11

    Topics: Ambroxol; Biological Transport; Blotting, Western; Bronchi; Calcium; Chlorides; Cystic Fibrosis; Cys

2013
[Functional examination of the lungs in evaluating the effect of respiratory rehabilitation and mucolytics in cystic fibrosis].
    Ceskoslovenska pediatrie, 1983, Volume: 38, Issue:9

    Topics: Adolescent; Adult; Ambroxol; Bromhexine; Child; Cystic Fibrosis; Female; Humans; Male; Respiratory F

1983
[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:4

    Topics: Adolescent; Adult; Ambroxol; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Deoxyr

1998